Lois Smith

Has grant

Professor in Ophthalmology

Harvard Medical School

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Lois Smith is a Professor in Ophthalmology at Harvard Medical School in the United States. Her research focuses on various aspects of retinal diseases, including retinopathy of prematurity, choroidal neovascularization, and metabolic risk factors associated with ocular conditions. Recent publications include studies on the therapeutic effects of supplementation in retinal diseases and the activation of specific receptors to suppress retinal neovascularization.

Recent Grants

Grant: Close

Studies in retinopathy

Open Date:

Close Date:

Articles (11)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Deokho Lee

Research Professor

Kagawa Nutrition University

SOUTH KOREA

View details

Staffan Nilsson

Göteborgs Universitet

SWEDEN

View details

Yohei Tomita

Senior assistant professor

Keio University School of Medicine

JAPAN

View details

Anders Nilsson

Göteborgs Universitet

SWEDEN

View details

Timothy Hla

Patricia Donahoe Professor, Harvard Medical School

Boston Children's Hospital/Harvard Medical School

UNITED STATES

View details

Edward Bull

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Ann Hellström

Professor

SWEDEN

View details

Richard Proia

National Institutes of Health

UNITED STATES

View details

ZHONGJIE FU

Assistant Professor

Boston Children's Hospital/Harvard Medical School

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lois Smith

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Choroidal Neovascularization Is Suppressed With Activation of TREM2 in Mononuclear Phagocytes—Brief Report

Association between Early Postnatal Hydrocortisone and Retinopathy of Prematurity in Extremely Preterm Infants

ROP: 80 Years after Its Detection – Where Do We Stand and How Long Will We Continue to Laser?

Therapeutic Effects of Taurine and Histidine Supplementation in Retinal Diseases

Therapeutic activation of endothelial sphingosine‐1‐phosphate receptor 1 by chaperone‐bound S1P suppresses proliferative retinal neovascularization

In vivo noninvasive mitochondrial redox assessment of the optic nerve head to predict disease

Retinopathy of prematurity: Metabolic risk factors

Murine endothelial serine palmitoyltransferase 1 (SPTLC1) is required for vascular development and systemic sphingolipid homeostasis

Validation of the Retinopathy of Prematurity Activity Scale (ROP‐ActS) using retrospective clinical data

Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP

Insulin-Like Growth Factor 1 in the Preterm Rabbit Pup: Characterization of Cerebrovascular Maturation following Administration of Recombinant Human Insulin-Like Growth Factor 1/Insulin-Like Growth Factor 1-Binding Protein 3

Collaborators (9)

Deokho Lee

Staffan Nilsson

Yohei Tomita

Anders Nilsson

Timothy Hla

Edward Bull

Ann Hellström

Richard Proia

ZHONGJIE FU

Make your next move.